InvestorsHub Logo
Followers 7
Posts 1303
Boards Moderated 0
Alias Born 03/08/2019

Re: None

Tuesday, 07/30/2019 10:02:17 PM

Tuesday, July 30, 2019 10:02:17 PM

Post# of 720
Hoping to get some bargain shares tomorrow to average down. The CEO has already stated that Beleave's current cultivation footprint produces approximately $5,000,000 in annual revenues in his recent interview. The company anticipates $50,000,000 annually when the current expansion is fully operational. Late filing is pretty common on the OTC, more interested in supply agreements, and new strains of dried flower & concentrate products. imho glta